Chemical Compound Review:
decylate decanoic acid
Synonyms:
caprynate, decanoate, decoate, Dekansaeure, Kaprinsaeure, ...
Johansen,
Mulligan,
Schambelan,
Baumann,
Ayestas,
Sharpe,
Lewis,
Rice,
Rothman,
Mulligan,
Zackin,
Clark,
Alston-Smith,
Liu,
Sattler,
Delvers,
Currier,
Jaanson,
Marandi,
Kiivet,
Vasar,
Vään,
Svensson,
Dahl,
Lamberti,
Crilly,
Maharaj,
Olson,
Wiener,
Dvorin,
Costea,
Bushey,
Dietz,
Schlussman,
Zhou,
Johansson,
Kiuru,
Ho,
Nyberg,
Kreek,
Johansen,
Painter,
Sakkas,
Gordon,
Doyle,
Shubert,
Covell,
Jackson,
Evans,
Essock,
- Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. Gold, J., High, H.A., Li, Y., Michelmore, H., Bodsworth, N.J., Finlayson, R., Furner, V.L., Allen, B.J., Oliver, C.J. AIDS (1996)
- Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Rosenberg, E.Y., Bertenthal, D., Nilles, M.L., Bertrand, K.P., Nikaido, H. Mol. Microbiol. (2003)
- Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Mulligan, K., Zackin, R., Clark, R.A., Alston-Smith, B., Liu, T., Sattler, F.R., Delvers, T.B., Currier, J.S. Arch. Intern. Med. (2005)
- Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis. Salartash, K., Lepore, M., Gonze, M.D., Leone-Bay, A., Baughman, R., Sternbergh, W.C., Bowen, J.C., Money, S.R. Ann. Surg. (2000)
- A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Gaughan, W.J., Liss, K.A., Dunn, S.R., Mangold, A.M., Buhsmer, J.P., Michael, B., Burke, J.F. Am. J. Kidney Dis. (1997)
- Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs. Lamberti, J.S., Crilly, J.F., Maharaj, K., Olson, D., Wiener, K., Dvorin, S., Costea, G.O., Bushey, M.P., Dietz, M.B. The Journal of clinical psychiatry. (2004)
- Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: a multicenter trial in general practice. Budde, G. Prog. Neuropsychopharmacol. Biol. Psychiatry (1992)
- A double-blind comparison of oral amitriptyline and low-dose intramuscular flupenthixol decanoate in depressive illness. Maragakis, B.P. Current medical research and opinion. (1990)
- Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation. Singh, A.N. J. Int. Med. Res. (1984)
- Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic. Pedersen, V., Svendsen, O., Danneskiold-Samsoe, P., Boeck, V., Nielsen, I.M. Acta pharmacologica et toxicologica. (1977)
- Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. Johansen, K.L., Mulligan, K., Schambelan, M. JAMA (1999)
- The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. Yaar, M., Eller, M.S., DiBenedetto, P., Reenstra, W.R., Zhai, S., McQuaid, T., Archambault, M., Gilchrest, B.A. J. Clin. Invest. (1994)
- Medium-chain fatty acid binding to albumin and transfer to phospholipid bilayers. Hamilton, J.A. Proc. Natl. Acad. Sci. U.S.A. (1989)
- Transport of long-chain fatty acids by Escherichia coli: mapping and characterization of mutants in the fadL gene. Nunn, W.D., Simons, R.W. Proc. Natl. Acad. Sci. U.S.A. (1978)
- Bullfrog ghrelin is modified by n-octanoic acid at its third threonine residue. Kaiya, H., Kojima, M., Hosoda, H., Koda, A., Yamamoto, K., Kitajima, Y., Matsumoto, M., Minamitake, Y., Kikuyama, S., Kangawa, K. J. Biol. Chem. (2001)
- Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters. van Balkom, R.H., Dekhuijzen, P.N., van der Heijden, H.F., Folgering, H.T., Fransen, J.A., van Herwaarden, C.L. Eur. Respir. J. (1999)
- Synthesis and bioevaluation of a series of fatty acid esters of p-[N,N-bis(2-chloroethyl)amino]phenol. Wynn, J.E., Caldwell, M.L., Robinson, J.R., Beamer, R.L., Bauguess, C.T. Journal of pharmaceutical sciences. (1982)
- Recurrent priapism as a side effect of zuclopenthixol decanoate. van Hemert, A.M., Meinhardt, W., Moehadjir, D., Kropman, R.F. International clinical psychopharmacology. (1995)
- Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. Need, A.G., Horowitz, M., Bridges, A., Morris, H.A., Nordin, B.E. Arch. Intern. Med. (1989)
- Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy. Van Loan, M.D., Strawford, A., Jacob, M., Hellerstein, M. AIDS (1999)
- Effect of nortestosterone decanoate on red cell 2,3 diphosphoglycerate and hematocrit in hemodialysis patients. Goodman, J., Bessman, A.N. Clin. Pharmacol. Ther. (1975)
- A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy. Wei, F.C., Jann, M.W., Lin, H.N., Piao-Chien, C., Chang, W.H. The Journal of clinical psychiatry. (1996)
- Diacylglycerol is an effector of the clonal expansion of cells containing activated Ha-ras genes. Mills, K.J., Reynolds, S.H., Smart, R.C. Carcinogenesis (1993)
- Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. Johansen, K.L., Painter, P.L., Sakkas, G.K., Gordon, P., Doyle, J., Shubert, T. J. Am. Soc. Nephrol. (2006)
- Haldol decanoate and thyroid disease. Jefferson, J.W. The Journal of clinical psychiatry. (1988)
- Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques. Obasanjo, I.O., Cline, J.M., Schmotzer, S., Weaver, D.S. Menopause (New York, N.Y.) (1998)
- Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate. Baumann, M.H., Ayestas, M.A., Sharpe, L.G., Lewis, D.B., Rice, K.C., Rothman, R.B. J. Pharmacol. Exp. Ther. (2002)
- Location of the medium chain fatty acid site on human serum albumin. Residues involved and relationship to the indole site. Lee, I.Y., McMenamy, R.H. J. Biol. Chem. (1980)
- Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia. Johnson, D.A., Ludlow, J.M., Street, K., Taylor, R.D. The British journal of psychiatry : the journal of mental science. (1987)
- Clopenthixol decanoate in the management of aggressive mentally handicapped patients. Mlele, T.J., Wiley, Y.V. The British journal of psychiatry : the journal of mental science. (1986)
- Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics. Wistedt, B., Palmstierna, T. The Journal of clinical psychiatry. (1983)
- Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat. Schlussman, S.D., Zhou, Y., Johansson, P., Kiuru, A., Ho, A., Nyberg, F., Kreek, M.J. Neurosci. Lett. (2000)
- A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Berns, J.S., Rudnick, M.R., Cohen, R.M. Clin. Nephrol. (1992)
- Effect of unesterified cholesterol on the activity of cholesteryl ester transfer protein. Rajaram, O.V., Chan, R.Y., Sawyer, W.H. Biochem. J. (1994)
- Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype. Jaanson, P., Marandi, T., Kiivet, R.A., Vasar, V., Vään, S., Svensson, J.O., Dahl, M.L. Psychopharmacology (Berl.) (2002)
- Synthesis of poly(3-hydroxyalkanoates) in Escherichia coli expressing the PHA synthase gene phaC2 from Pseudomonas aeruginosa: comparison of PhaC1 and PhaC2. Qi, Q., Rehm, B.H., Steinbüchel, A. FEMS Microbiol. Lett. (1997)
- Calcium-deficient diet in ovariectomized dogs limits the effects of 17 beta-estradiol and nandrolone decanoate on bone. Geusens, P., Schot, L.P., Nijs, J., Dequeker, J. J. Bone Miner. Res. (1991)
- Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents. Lewis, D.B., Matecka, D., Zhang, Y., Hsin, L.W., Dersch, C.M., Stafford, D., Glowa, J.R., Rothman, R.B., Rice, K.C. J. Med. Chem. (1999)
- Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings. Turbott, J., Villiger, J., Hunter, L. The British journal of psychiatry : the journal of mental science. (1985)
- Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles. Covell, N.H., Jackson, C.T., Evans, A.C., Essock, S.M. Schizophrenia bulletin. (2002)
- Behavioral effects produced by long-term administration of a neuroleptic drug (flupenthixol) upon social interaction in a group of eight rats. Hecht, A. Psychopharmacology (Berl.) (1979)